Vitafoods Europe 2018

May 2018

NattoPharma ASA

NattoPharma ASA
NattoPharma, the vitamin K2 R&D leader, continues to invest in true clinical science that further substantiates the bone and heart benefits of MenaQ7 Vitamin K2 as MK-7, the expert brand. The company claims to deliver the most comprehensive K2 portfolio on the market, meeting manufacturers’ and consumers’ needs. At this year’s Vitafoods Europe, NattoPharma introduces its new CryoCap, a microencapsulated MenaQ7 Vitamin K2. An advanced protective technology developed to ensure Vitamin K2 stability in even the most complex formulations, this solution-driven innovation ensures finished products deliver the proven benefits of MenaQ7 Vitamin K2, creating unparalleled value.
Stand: C24
www.menaq7.com

EventImage